Glycosides and Vaccines is the 11th most traded product and the 82nd most complex product according to the Product Complexity Index (PCI).
The top exporters of Glycosides and Vaccines are Switzerland ($26.2B), Germany ($22.9B), the United States ($20.6B), Belgium ($13.9B) and Ireland ($10.8B). The top importers are the United States ($20.7B), Germany ($18.7B), Belgium ($11.1B), the United Kingdom ($10.1B) and Switzerland ($7.53B).
Glycosides and Vaccines is also known as glands, antisera, organo-therapeutic, toxins, microbial cultures.
Glycosides and Vaccines is a 4 digit SITC product.